In a 3-year analysis of the FAVOR III China trial, published Oct. 1, 2026, in JAMA Network Open, stents guided by a flow measurement called QFR were linked to fewer major heart events in people with several narrowed arteries (12.1%…
In California, opening a hospital able to unblock heart arteries with stents within 30 minutes of a community without one was linked to 20% lower 30-day mortality after a heart attack. In areas already served, there was no mortality change.
Pooling seven studies with 121,480 patients who had a coronary stent, a moderate-intensity statin plus ezetimibe was linked to a lower risk of new diabetes (RR 0.83) and similar heart events compared with a high-intensity statin.